全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1308652-64-3 | 9-[2-(Dicyclohexylphosphino)phenyl]-9H-carbazole;(2-carbazol-9-ylphenyl)-dicyclohexylphosphane | C30H34NP |
| 1308671-90-0 | 3-(5-Bromo-2-thienyl)-2,5-bis(2-ethylhexyl)-2,5-dihydro-6-(2-thienyl)pyrrolo[3,4-c]pyrrole-1,4-dione | C30H39BrN2O2S2 |
| 1308672-74-3 | Surufatinib;N-[2-(Dimethylamino)ethyl]-3-[[4-[(2-methyl-1H-indol-5-yl)oxy]-2-pyrimidinyl]amino]benzenemethanesulfonamide | C24H28N6O3S |
| 1309362-77-3 | Cerberic acid B;(alphaR)-3-Carboxy-alpha-hydroxybenzenepropanoic acid | C10H10O5 |
| 1309684-94-3 | RO 8994;(2'S,3R,4'S,5'R)-N-[4-(Aminocarbonyl)-2-methoxyphenyl]-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-2-oxo-spiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide | C31H31Cl2FN4O4 |
| 1309784-09-5 | ITK inhibitor 2;(2S)-N-[2-(6,6-dimethyl-1,4,5,7-tetrahydroindazol-3-yl)-1H-indol-6-yl]-N-methyl-2-morpholin-4-ylpropanamide | C25H33N5O2 |
| 1309788-49-5 | 6,6-Dimethyl-4,5,6,7-tetrahydro-1H-indazole | C9H14N2 |
| 1309933-98-9 | 5-Bromo-1,3-difluoro-2-(1-methylethoxy)benzene | C9H9BrF2O |
| 1309976-62-2 | VU 0360172 | C18H16ClFN2O |
| 1309982-68-0 | 3-Fluoropyridine-2-boronic acid pinacol ester;3-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | C11H15BFNO2 |
| 1310146-00-9 | trans-1,4-Dihydroxycyclohexaneacetic acid | C8H14O4 |
| 1310381-54-4 | 3-Oxetaneacetic acid | C5H8O3 |
| 1310383-01-7 | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinol | C11H16BNO3 |
| 1310383-58-4 | 5-Chloro-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | C11H14BClFNO2 |
| 1310383-91-5 | [3-Formyl-4-(trifluoromethoxy)phenyl]boronic acid | C8H6BF3O4 |
| 1310384-22-5 | 2-Benzyloxy-5-formylphenylboronic acid;B-[5-Formyl-2-(phenylmethoxy)phenyl]boronic acid | C14H13BO4 |
| 1310403-86-1 | Quinolin-6-ylboronic acid hydrochloride | C9H8BNO2.HCl |
| 1310404-17-1 | (6-(Methoxycarbonyl)pyridin-2-yl)boronic acid | C7H8BNO4 |
| 1310405-04-9 | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2(1H)-pyridinone | C11H16BNO3 |
| 1310422-41-3 | SEP-363856 hydrochloride;1-[(7S)-5,7-dihydro-4H-thieno[2,3-c]pyran-7-yl]-N-methylmethanamine;hydrochloride | C9H14ClNOS |
| 1310584-14-5 | (SP-4-4)-[2'-Amino[1,1'-biphenyl]-2-yl]chloro[dicyclohexyl[2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine]palladium | C45H59ClNPPd |
| 1310693-92-5 | Tubastatin A hydrochloride;N-Hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide hydrochloride | C20H21N3O2.HCl |
| 1310726-60-3 | Upadacitinib;(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; ABT 494 | C17H19F3N6O |
| 1311197-82-6 | 5-Iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole | C8H11IN2O |
| 1311254-72-4 | 5,6,7,8-Tetrahydro-6-(phenylmethyl)pyrido[4,3-d]pyrimidin-4(4aH)-one | C14H15N3O |
| 1311254-73-5 | 3-(N-(4-methoxybenzyl)-4-methylphenylsulfonamido)propanoic acid | C18H21NO5S |
| 1311254-74-6 | tert-butyl 2-methoxy-2-methylpropylcarbamate | C10H21NO3 |
| 1311254-79-1 | 4-Amino-2-(Boc-amino)-5-methylpyridine | C11H17N3O2 |
| 1311265-17-4 | 1-[(4-Bromophenoxy)methyl]cyclopropanecarboxylic acid ethyl ester | C13H15BrO3 |
| 1311367-27-7 | BIX 02565;(5R)-N-[1-[3-(Dimethylamino)propyl]-1H-benzimidazol-2-yl]-2,3,4,5-tetrahydro-5-methyl-1-oxo-1H-[1,4]diazepino[1,2-a]indole-8-carboxamide | C26H30N6O2 |
| 1311385-32-6 | (1R,2S,4R,5R,6R)-2-[[(2S)-2-Amino-1-oxopropyl]amino]-4-(1H-1,2,4-triazol-5-ylthio)-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid ammonium salt hydrate (1:1:1) | C13H17N5O5S.NH3.H2O |
| 1311408-02-2 | 4-(Carbazol-9-yl)biphenyl-4'-boronic acid pinacol ester;2-[4-(Carbazol-9-yl)biphenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; 9-(4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-4-yl)-9H-carbazole | C30H28BNO2 |
| 1311484-45-3 | 3-Nitrophenylboronic acid MIDA ester | |
| 1311484-50-0 | 1-(p-Toluenesulfonyl)pyrrole-2-boronic acid MIDA ester | |
| 1311933-82-0 | (2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-5-hexenoic acid | C22H23NO4 |
| 1311933-83-1 | (2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-8-nonenoic acid | C25H29NO4 |
| 1311933-84-2 | (2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-8-nonenoic acid | C25H29NO4 |
| 1311992-92-3 | 3-Bromo-alpha-methyl-6-quinolineacetic acid ethyl ester | C14H14BrNO2 |
| 1311992-97-8 | 2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-(2-propen-1-yl)-4-pentenoic acid | C23H23NO4 |
| 1311992-98-9 | 2-(3-Buten-1-yl)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-5-hexenoic acid | C25H27NO4 |
| 1312118-15-2 | 4,7-Dibromo-2-(heptadecan-9-yl)-2H-benzo[1,2,3]triazole | C23H37Br2N3 |
| 1312161-60-6 | Benzyl N-[[(3R)-morpholin-3-yl]methyl]carbamate | C13H18N2O3 |
| 1312161-61-7 | (3S)-3-(Aminomethyl)-4-morpholinecarboxylic acid phenylmethyl ester | C13H18N2O3 |
| 1312161-62-8 | (3R)-3-(Aminomethyl)-4-morpholinecarboxylic acid phenylmethyl ester | C13H18N2O3 |
| 1312161-63-9 | Benzyl N-[[(3S)-morpholin-3-yl]methyl]carbamate | C13H18N2O3 |
| 1312445-63-8 | Buparlisib hydrochloride;5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine hydrochloride (1:1); BKM 120AAA | C18H21F3N6O2.HCl |
| 1312535-22-0 | N-(3-Bromo-5-methylphenyl)-4-methylpyrimidin-2-amine | C12H12BrN3 |
| 1312535-32-2 | 2,2-Dimethyl-4-oxocyclohexanecarboxylic acid methyl ester;Methyl 2,2-dimethyl-4-oxocyclohexanecarboxylate | C10H16O3 |
| 1312692-51-5 | (1R,2S)-4,4-Difluorocyclopentane-1,2-diamine dihydrochloride | C5H12Cl2F2N2 |
| 1312693-69-8 | 4,6-Dichloro-7-fluoro-1H-pyrrolo[3,4-c]pyridin-3(2H)-one | C7H3Cl2FN2O |